Literature DB >> 22648518

Local recurrence of localized soft tissue sarcoma: a new look at old predictors.

David J Biau1, Peter C Ferguson, Peter Chung, Anthony M Griffin, Charles N Catton, Brian O'Sullivan, Jay S Wunder.   

Abstract

BACKGROUND: The objective of this study was to examine the effect of known predictors of local recurrence of soft tissue sarcoma in a competing risk setting.
METHODS: The outcome of interest was the cumulative probability of local recurrence per category of relevant predictors, with death as a competing event. In total, 1668 patients with a localized soft tissue sarcoma of the extremity or trunk were included.
RESULTS: Tumor size (hazard ratio, 3.3), depth (hazard ratio, 3.2), and histologic grade (hazard ratio, 4.5) were the variables that had the most effect on the risk of metastasis and, accordingly, were the most likely to induce competition. Surgical margins (hazard ratio, 3.3), histologic grade (hazard ratio, 2.1), presentation status (hazard ratio, 2.4), and tumor depth (hazard ratio, 1.5) were the variables that had the most effect on the risk of local recurrence. The 10-year cumulative probabilities of local recurrence were markedly different within categories for presentation status (P < .001) and surgical margin status (P < .001). However, because of the competing effect of death, there was little difference in the 10-year cumulative probabilities of local recurrence with regard to tumor depth (12% and 11.4% for deep and superficial tumors, respectively; P = .2), tumor size (10.6% and 13.3% for large and small tumors, respectively; P = .99), or histologic tumor grade (12.6%, 10.7%, and 11.1% for high, intermediate, and low-grade tumors, respectively; P = .17).
CONCLUSIONS: Because of the competition between local recurrence and death, histologic tumor grade, tumor size, and tumor depth had little influence on the cumulative probability of local recurrence. The authors concluded that local management should be based on presentation status and surgical margins rather than other, previously acknowledged factors.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22648518     DOI: 10.1002/cncr.27639

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  33 in total

1.  The accurate surgical margin before surgery for malignant musculoskeletal tumors: a retrospective study.

Authors:  Yun Hao; Caihong Yang; Jinpeng He
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival.

Authors:  Julie Willeumier; Marta Fiocco; Remi Nout; Sander Dijkstra; William Aston; Rob Pollock; Henk Hartgrink; Judith Bovée; Michiel van de Sande
Journal:  Int Orthop       Date:  2015-03-07       Impact factor: 3.075

3.  Lymphadenopathy in Fungating Extremity Soft-Tissue Sarcoma: Metastasis or Reactive?

Authors:  Nicholas M Siegel; Santiago A Lozano-Calderón; Jad M El Abiad; Carol D Morris; Adam S Levin
Journal:  Ann Surg Oncol       Date:  2021-01-03       Impact factor: 5.344

4.  Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis.

Authors:  Alicia A Gingrich; Sarah B Bateni; Arta M Monjazeb; Morgan A Darrow; Steven W Thorpe; Amanda R Kirane; Richard J Bold; Robert J Canter
Journal:  Ann Surg Oncol       Date:  2017-07-24       Impact factor: 5.344

5.  Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors.

Authors:  Daniel Y Joh; Gary D Kao; Surya Murty; Melissa Stangl; Lova Sun; Ajlan Al Zaki; Xiangsheng Xu; Stephen M Hahn; Andrew Tsourkas; Jay F Dorsey
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

6.  Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma.

Authors:  David A J Wilson; Aaron Gazendam; Julia Visgauss; David Perrin; Anthony M Griffin; Peter W Chung; Charles N Catton; David Shultz; Peter C Ferguson; Jay S Wunder
Journal:  Ann Surg Oncol       Date:  2020-03-09       Impact factor: 5.344

7.  Higher complications after previous external beam radiation for extremity soft-tissue sarcoma in the surgical treatment of a local recurrence: a comparative retrospective study of one hundred and three patients.

Authors:  Gauthier Eloy; Caroline Daveau; Sarah Kreps; Pascaline Boudou-Rouquette; Philippe Anract; David Biau
Journal:  Int Orthop       Date:  2018-07-25       Impact factor: 3.075

Review 8.  Follow-up Strategies for Primary Extremity Soft-tissue Sarcoma in Adults: A Systematic Review of the Published Literature.

Authors:  Dietmar Dammerer; Annelies VAN Beeck; Viktoria Schneeweiss; Anton Schwabegger
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 9.  Li-Fraumeni syndrome: cancer risk assessment and clinical management.

Authors:  Kate A McBride; Mandy L Ballinger; Emma Killick; Judy Kirk; Martin H N Tattersall; Rosalind A Eeles; David M Thomas; Gillian Mitchell
Journal:  Nat Rev Clin Oncol       Date:  2014-03-18       Impact factor: 66.675

10.  Soft Tissue Cancer Management: Isolated Limb Infusion for Sarcoma.

Authors:  Jyri Teras; Andrus Mägi; Marina Teras; Pille Pata; Roland M Teras; Neena Randhawa; Kristjan Kalling
Journal:  Visc Med       Date:  2019-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.